1451 related articles for article (PubMed ID: 29129819)
21. Altered lipid metabolism in Hfe-knockout mice promotes severe NAFLD and early fibrosis.
Tan TC; Crawford DH; Jaskowski LA; Murphy TM; Heritage ML; Subramaniam VN; Clouston AD; Anderson GJ; Fletcher LM
Am J Physiol Gastrointest Liver Physiol; 2011 Nov; 301(5):G865-76. PubMed ID: 21817060
[TBL] [Abstract][Full Text] [Related]
22. Decreased α7nAChR mRNA levels in peripheral blood monocytes are associated with enhanced inflammatory cytokine production in patients with lupus nephritis.
Xu H; Li J; Zhang L; Li N; Su S; Ye Z; Xu Y
Biomed Pharmacother; 2019 Mar; 111():359-366. PubMed ID: 30594048
[TBL] [Abstract][Full Text] [Related]
23. Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122.
Chai C; Cox B; Yaish D; Gross D; Rosenberg N; Amblard F; Shemuelian Z; Gefen M; Korach A; Tirosh O; Lanton T; Link H; Tam J; Permyakova A; Ozhan G; Citrin J; Liao H; Tannous M; Hahn M; Axelrod J; Arretxe E; Alonso C; Martinez-Arranz I; Betés PO; Safadi R; Salhab A; Amer J; Tber Z; Mengshetti S; Giladi H; Schinazi RF; Galun E
Gastroenterology; 2020 Sep; 159(3):999-1014.e9. PubMed ID: 32450149
[TBL] [Abstract][Full Text] [Related]
24. Emodin palliates high-fat diet-induced nonalcoholic fatty liver disease in mice via activating the farnesoid X receptor pathway.
Shen C; Pan Z; Wu S; Zheng M; Zhong C; Xin X; Lan S; Zhu Z; Liu M; Wu H; Huang Q; Zhang J; Liu Z; Si Y; Tu H; Deng Z; Yu Y; Liu H; Zhong Y; Guo J; Cai J; Xian S
J Ethnopharmacol; 2021 Oct; 279():114340. PubMed ID: 34171397
[TBL] [Abstract][Full Text] [Related]
25. Nonalcoholic Fatty Liver Disease Is Exacerbated in High-Fat Diet-Fed Gnotobiotic Mice by Colonization with the Gut Microbiota from Patients with Nonalcoholic Steatohepatitis.
Chiu CC; Ching YH; Li YP; Liu JY; Huang YT; Huang YW; Yang SS; Huang WC; Chuang HL
Nutrients; 2017 Nov; 9(11):. PubMed ID: 29113135
[TBL] [Abstract][Full Text] [Related]
26. Treatment of experimental non-alcoholic steatohepatitis by targeting α7 nicotinic acetylcholine receptor-mediated inflammatory responses in mice.
Zhou Z; Liu YC; Chen XM; Li FQ; Tong XJ; Ding YP; Tang CL
Mol Med Rep; 2015 Nov; 12(5):6925-31. PubMed ID: 26397391
[TBL] [Abstract][Full Text] [Related]
27. A retinoic acid receptor β2 agonist reduces hepatic stellate cell activation in nonalcoholic fatty liver disease.
Trasino SE; Tang XH; Jessurun J; Gudas LJ
J Mol Med (Berl); 2016 Oct; 94(10):1143-1151. PubMed ID: 27271256
[TBL] [Abstract][Full Text] [Related]
28. Nicotinic ACh receptor α7 inhibits PDGF-induced migration of vascular smooth muscle cells by activating mitochondrial deacetylase sirtuin 3.
Li DJ; Tong J; Zeng FY; Guo M; Li YH; Wang H; Wang P
Br J Pharmacol; 2019 Nov; 176(22):4388-4401. PubMed ID: 30270436
[TBL] [Abstract][Full Text] [Related]
29. Helicobacter pylori infection aggravates diet-induced nonalcoholic fatty liver in mice.
He C; Cheng D; Wang H; Wu K; Zhu Y; Lu N
Clin Res Hepatol Gastroenterol; 2018 Sep; 42(4):360-367. PubMed ID: 29657020
[TBL] [Abstract][Full Text] [Related]
30. CD47 Deficiency in Mice Exacerbates Chronic Fatty Diet-Induced Steatohepatitis Through Its Role in Regulating Hepatic Inflammation and Lipid Metabolism.
Tao HC; Chen KX; Wang X; Chen B; Zhao WO; Zheng Y; Yang YG
Front Immunol; 2020; 11():148. PubMed ID: 32158445
[TBL] [Abstract][Full Text] [Related]
31. Activation of α7nACh receptor protects against acute pancreatitis through enhancing TFEB-regulated autophagy.
Li B; Wu J; Bao J; Han X; Shen S; Ye X; Dai J; Wu Z; Niu M; He Y; Ni J; Wen L; Wang X; Hu G
Biochim Biophys Acta Mol Basis Dis; 2020 Dec; 1866(12):165971. PubMed ID: 32950676
[TBL] [Abstract][Full Text] [Related]
32. Genetic inactivation of the LIGHT (TNFSF14) cytokine in mice restores glucose homeostasis and diminishes hepatic steatosis.
Herrero-Cervera A; Vinué Á; Burks DJ; González-Navarro H
Diabetologia; 2019 Nov; 62(11):2143-2157. PubMed ID: 31388695
[TBL] [Abstract][Full Text] [Related]
33. Alpha7 Nicotine Acetylcholine Receptor Agonist PNU-282987 Attenuates Acute Lung Injury in a Cardiopulmonary Bypass Model in Rats.
Ge J; Tian J; Yang H; Hou L; Wang Z; He Z; Wang X
Shock; 2017 Apr; 47(4):474-479. PubMed ID: 27661000
[TBL] [Abstract][Full Text] [Related]
34. Disruption of tumor necrosis factor alpha receptor 1 signaling accelerates NAFLD progression in mice upon a high-fat diet.
Lambertucci F; Arboatti A; Sedlmeier MG; Motiño O; Alvarez ML; Ceballos MP; Villar SR; Roggero E; Monti JA; Pisani G; Quiroga AD; Martín-Sanz P; Carnovale CE; Francés DE; Ronco MT
J Nutr Biochem; 2018 Aug; 58():17-27. PubMed ID: 29860102
[TBL] [Abstract][Full Text] [Related]
35. Intermittent restraint-induced sympathetic activation attenuates hepatic steatosis and inflammation in a high-fat diet-fed mouse model.
Lee SB; Kim HG; Lee JS; Kim WY; Lee MM; Kim YH; Lee JO; Kim HS; Son CG
Am J Physiol Gastrointest Liver Physiol; 2019 Dec; 317(6):G811-G823. PubMed ID: 31604029
[TBL] [Abstract][Full Text] [Related]
36. Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1.
Zhang Y; Geng C; Liu X; Li M; Gao M; Liu X; Fang F; Chang Y
Mol Metab; 2017 Jan; 6(1):138-147. PubMed ID: 28123944
[TBL] [Abstract][Full Text] [Related]
37. JIP3 knockout protects mice against high fat diet-induced liver injury.
Ma XJ; Xing HZ; Ren GF; Rao XJ; Li ZZ
Biochem Biophys Res Commun; 2018 Mar; 497(3):819-826. PubMed ID: 29454969
[TBL] [Abstract][Full Text] [Related]
38. Dysfunction of the cholinergic anti-inflammatory pathway mediates organ damage in hypertension.
Li DJ; Evans RG; Yang ZW; Song SW; Wang P; Ma XJ; Liu C; Xi T; Su DF; Shen FM
Hypertension; 2011 Feb; 57(2):298-307. PubMed ID: 21173343
[TBL] [Abstract][Full Text] [Related]
39. Activating α7 nicotinic acetylcholine receptor inhibits NLRP3 inflammasome through regulation of β-arrestin-1.
Ke P; Shao BZ; Xu ZQ; Chen XW; Wei W; Liu C
CNS Neurosci Ther; 2017 Nov; 23(11):875-884. PubMed ID: 28941191
[TBL] [Abstract][Full Text] [Related]
40. Pu-erh tea extract ameliorates high-fat diet-induced nonalcoholic steatohepatitis and insulin resistance by modulating hepatic IL-6/STAT3 signaling in mice.
Cai X; Fang C; Hayashi S; Hao S; Zhao M; Tsutsui H; Nishiguchi S; Sheng J
J Gastroenterol; 2016 Aug; 51(8):819-29. PubMed ID: 26794005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
